Readcrest Capital AG (Frankfurt:EXJ0.F)
| Market Cap | 41.54M-4.6% |
| Revenue (ttm) | n/a |
| Net Income | -102.30K |
| EPS | -1.26 |
| Shares Out | 33.24M |
| PE Ratio | n/a |
| Forward PE | 4.63 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 130 |
| Open | 1.25 |
| Previous Close | 1.25 |
| Day's Range | 1.25 - 1.25 |
| 52-Week Range | 0.48 - 1.65 |
| Beta | 1.16 |
| Analysts | Strong Buy |
| Price Target | 2.80(+124.00%) |
| Earnings Date | n/a |
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
About EXJ0.F
Readcrest Capital AG operates in the healthcare services sector. The company provides services in the area of outpatient and inpatient care, as well as the provision of nursing staff. It is also involved in the development and management of mixed-use real estate projects. Readcrest Capital AG is based in Hamburg, Germany.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$EXJ0.F stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in EXJ0.F holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by EXJ0.F's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
EXJ0.F Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New EXJ0.F patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to EXJ0.F from public contracts
Source: USAspending.gov
EXJ0.F Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from EXJ0.F’s recent data — informational, not investment advice